Ewelina Kreft, Kornelia Sałaga-Zaleska, Monika Sakowicz-Burkiewicz, Kamil Dąbkowski, Miroslawa Szczepánska-Konkel, Maciej Jankowski
Journal of vascular research 2021Diabetes through adenosine A1 receptor (A1R) and P2 receptors (P2Rs) may lead to disturbances in renal microvasculature. We investigated the renal microvascular response to Ap4A, an agonist of P2Rs, in streptozotocin-induced diabetic rats. Using laser Doppler flowmetry, renal blood perfusion (RBP) was measured during infusion of Ap4A alone or in the presence of A1R antagonist, either DPCPX (8-cyclopentyl-1,3-dipropylxanthine) or 8-cyclopentyltheophylline (CPT). Ap4A induced a biphasic response in RBP: a phase of rapid decrease was followed by a rapid increase, which was transient in diabetic rats but extended for 30 min in nondiabetic rats. Phase of decreased RBP was not affected by DPCPX or CPT in either group. Early and extended increases in RBP were prevented by DPCPX and CPT in nondiabetic rats, while in diabetic rats, the early increase in RBP was not affected by these antagonists. A1R mRNA and protein levels were increased in isolated glomeruli of diabetic rats, but no changes were detected in P2Y1R and P2Y2R mRNA. Presence of unblocked A1R is a prerequisite for the P2R-mediated relaxing effect of Ap4A in nondiabetic conditions, but influence of A1R on P2R-mediated renal vasorelaxation is abolished under diabetic conditions. © 2020 S. Karger AG, Basel.
Ewelina Kreft, Kornelia Sałaga-Zaleska, Monika Sakowicz-Burkiewicz, Kamil Dąbkowski, Miroslawa Szczepánska-Konkel, Maciej Jankowski. Diabetes Affects the A1 Adenosine Receptor-Dependent Action of Diadenosine Tetraphosphate (Ap4A) on Cortical and Medullary Renal Blood Flow. Journal of vascular research. 2021;58(1):38-48
Mesh Tags
Substances
PMID: 33207336
View Full Text